Using Chronobiology to Improve Lenvatinib Efficacy
Status:
RECRUITING
Trial end date:
2024-06-01
Target enrollment:
Participant gender:
Summary
The goal of this proof-of-concept clinical trial is to assess the efficacy and safety of chronobiology implementation into lenvatinib treatment regimens of thyroid cancer patients, via a mobile application.
Participants will use a mobile application to follow variability-based physician approved drug administration schedules.